Call Us : (215) 310-8390
Home
Newsroom
Capabilities
Leadership
Life Science Digest
White Papers
Ipilimumab Approval Highlights Immunotherapy Renaissance
On March 25, 2011, Yervoy® [ipilimumab] by Bristol-Myers Squibb became the eleventh mAb approved by the FDA for the treatment of cancer.
March 25, 2011
by
Michael Becker
0 Comment
antibodies
,
cancer
,
immunotherapy
,
mab
,
monoclonal antibody
,
vaccine
© 2013-2018 MDB Communications LLC. All Rights Reserved. Please read our
Legal Disclaimer
Phone: (215) 310-8390